Expression of RUNX1-ETO Rapidly Alters the Chromatin Landscape and Growth of Early Human Myeloid Precursor Cells
2020 · Cell Reports · 32 citations
https://doi.org/10.1016/j.celrep.2020.107691
P
Peter Keane
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
59
Papers
1.6K
Citations
20
h-index
28
i10-index
Peter Keane is an academic researcher from University of Birmingham. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Epigenetics and DNA Methylation & Protein Degradation and Inhibitors. The author has an h-index of 20, co-authored 51 publications.
ORCID: 0000-0001-8738-9693Papers by this author
worksChromatin Priming Renders T Cell Tolerance-Associated Genes Sensitive to Activation below the Signaling Threshold for Immune Response Genes
2020 · Cell Reports · 30 citations
https://doi.org/10.1016/j.celrep.2020.107748
Identification and interrogation of the gene regulatory network of CEBPA-double mutant acute myeloid leukemia
2022 · Leukemia · 19 citations
https://doi.org/10.1038/s41375-022-01744-5
Gene regulatory network analysis predicts cooperating transcription factor regulons required for FLT3-ITD+ AML growth
2023 · Cell Reports · 12 citations
https://doi.org/10.1016/j.celrep.2023.113568
Pharmacological inhibition of RAS overcomes FLT3 inhibitor resistance in FLT3-ITD+ AML through AP-1 and RUNX1
2024 · iScience · 9 citations
https://doi.org/10.1016/j.isci.2024.109576
A heterozygous CEBPA mutation disrupting the bZIP domain in a RUNX1 and SRSF2 mutational background causes MDS disease progression
2025 · Nature Communications · 2 citations
https://doi.org/10.1038/s41467-025-60192-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat